Stock REGN REGENERON PHARMACEUTICALS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Official Publications Regeneron Pharmaceuticals, Inc.

Equities

REGN

US75886F1075

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
985 USD +0.45% Intraday chart for Regeneron Pharmaceuticals, Inc. +1.76% +12.15%
May. 23 Regeneron Pharmaceuticals Says GN7075 Plus Libtayo Shows Anti-Tumor Responses in Microsatellite Stable Colorectal Cancer MT
May. 23 Regeneron Pharmaceuticals, Inc. Announces Positive New Results from an Ongoing Phase 1/2 Trial Evaluating its First-in-Class Costimulatory Bispecific Antibody, REGN7075 CI

Official Publications

Slide show Q1 CO
1st quarter results CO
SEC Filing 10Q-1 CO
SEC Filing 8K CO
SEC Filing 10K CO
SEC Filing 8K CO
Slide show results CO
Annual results CO
SEC Filing 8K CO
SEC Filing 8K CO
3rd quarter results CO
SEC Filing 10Q-3 CO
Slide show Q3 CO
Slide show half-year results CO
1st-half-year results CO
SEC Filing 10Q-2 CO
SEC Filing 8K CO
Slide show Q1 CO
SEC Filing 10Q-1 CO
1st quarter results CO
Proxy Statments CO
Annual ESG Report CO
SEC Filing 10K CO
SEC Filing 8K CO
Slide show results CO
12
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies
  1. Stock Market
  2. Equities
  3. REGN Stock
  4. News Regeneron Pharmaceuticals, Inc.
  5. Official Publications